Implantable automatic cardioverter/defibrillators are now commonly used to treat malignant ventricular arrhythmias.' Early models simply detected a rapid heart rate and delivered a defibrillation shock, but more modem devices can deliver treatment as a tiered strategy of antitachycardia pacing, synchronised low energy cardioversion, and high energy defibrillation. Probability density function was used in the earliest implantable defibrillators'6: the function calculates the time spent by the sensed electrogram close to the baseline. In organised rhythms, electrogram analysis results in a well defined peak representing the baseline. In ventricular fibrillation, however, there will appear a random scatter of points, with no peak around the baseline amplitude.'6 If used in isolation, this sensing system is independent of rate, and will only diagnose arrhythmias similar in configuration to ventricular fibrillation.
Implantable automatic cardioverter/defibrillators are now commonly used to treat malignant ventricular arrhythmias.' Early models simply detected a rapid heart rate and delivered a defibrillation shock, but more modem devices can deliver treatment as a tiered strategy of antitachycardia pacing, synchronised low energy cardioversion, and high energy defibrillation.2' Accurate detection and diagnosis of arrhythmias is essential to avoid inappropriate intervention: unnecessary shocks cause battery depletion, increase patient morbidity, and may cause degeneration from a stable to a poorly tolerated rhythm. 45 An ideal system should treat haemodynamically unstable arrhythmias with a defibrillation shock, attempt pacing termination of stable ventricular tachycardia, and remain silent during stable atrial arrhythmias. Atrial fibrillation is common in patients with ventricular arrhyth- 6 mias, and a rapid ventricular response may suggest a ventricular arrhythmia to an unsophisticated detection system. No currently available automatic detection system can reliably distinguish these situations.
Automatic tachycardia recognition by implanted antitachycardia devices depends on correct sensing and interpretation of physiological changes. Ideally, the sensed variable should alter rapidly with changes in rhythm and recover promptly after normal rhythm is restored. We describe the currently available methods for automatic tachycardia recognition and review future trends. The Therefore, sensing of a haemodynamic variable, in combination with electrical events, is desirable. Because of the thromboembolic risk associated with chronic instrumentation of the left heart, studies have concentrated on the response to arrhythmias in the right heart. PHYSIOLOGICAL RESPONSES TO TACHYCARDIA In a thorough evaluation of the haemodynamic consequences of arrhythmias, Nakano showed that both atrial and ventricular tachycardias are associated with a decrease in mean arterial pressure, stroke volume, and cardiac output, and consequently an increase in atrial pressure bilaterally. 47 The interatrial pressure gradient increases in proportion to heart rate acceleration. Increased pulmonary artery pressure and total pulmonary resistance may largely be due to the increases in left atrial pressure. After onset of tachycardia there is partial haemodynamic recovery and increased myocardial contractility caused by catecholamine activity. 47 The magnitude of haemodynamic change is greater for ventricular arrhythmias because of abnormal patterns of ventricular contraction and periodic mitral regurgitation, caused by atrioventricular dissociation, that are associated with variable ventricular systolic and end diastolic pressures. 47 However, echocardiography during arrhythmias has failed to demonstrate an increased incidence or severity of mitral regurgitation during stable ventricular tachycardia in humans, and impaired cardiac performance was believed to reflect reduced ventricular diastolic filling. 48 Large atrial waves during arrhythmias may also represent cannon waves as the atria contract against closed atrioventricular valves. 49 In sinus tachycardia in response to exercise, mixed venous oxygen saturation falls promptly, in line with the increase in heart rate, with changes achieved in less than 10 seconds. Stroke volume also responds quickly to exercise but does not reflect the level of exertion. Maximal right ventricular pressure and dP/dt and mean right atrial pressure increase rapidly (over 10 seconds) with exercise, and the changes observed correlate well with workload.50
RIGHT VENTRICULAR PRESSURE MEASUREMENT Right ventricular pressure was sensed by the first laboratory model for the implantable defibrillator. Abolition of the phasic nature of this pressure triggered charging of the capacitor discharge circuit.5" During rapid right ventricular pacing to simulate ventricular tachycardia, mean right ventricular pressure showed a significant (mean increase 45%) and sustained increase in dogs.52 However, in humans rapid ventricular pacing at a comparable rate did not cause significant fluctuation in right ventricular pressure.5 Conversely, a rapid fall in right ventricular systolic and pulse pressures at the onset of ventricular arrhythmias has also been demonstrated. 54 Changes in right ventricular pressure occurred within two seconds of tachycardia onset. By estimating the ratio of right ventricular pulse pressure during tachycardia and at baseline, it was possible to discriminate between stable and unstable ventricular tachycardia, though in stable cases drift back to baseline over 30 seconds was noted. Evidence of some correlation between the fall in right ventricular pulse pressure and the associated fall in systemic arterial pressure has been noted, but with poor correlation with tachycardia cycle length. 55 Because there is large intra-group variability changes in right ventricular pulse pressure do not allow sinus tachycardia to be distinguished from haemodynamically stable or unstable ventricular or supraventricular tachycardia.56 Changes in dP/dt distinguished between unstable ventricular tachycardia and sinus tachycardia, but again there was extensive overlap between arrhythmia groups. 56 
Conclusions
Over a short period the implantable defibrillator has developed from a simple device for tachycardia detection and delivering shocks into a system in which sophisticated tiered anti-tachycardia pacing and cardioversion is now possible. To avoid spurious shocks and to optimise device performance a detection system giving increased diagnostic accuracy is desirable. This may necessitate a multisensor system, using both electrical and haemodynamic data. Dual chamber defibrillators will soon be available and may help overcome some problems in tachycardia diagnosis, particularly the difficulties in the detection of atrial fibrillation. The addition of a haemodynamic sensor might allow more appropriate application of tiered treatment. With further advances in lead and microprocessor technology a detection system capable of diagnosing all arrhythmias and determining their haemodynamic state should become a practical reality.
